Results 121 to 130 of about 2,501,072 (180)

Menopause Hormone Therapy in Women With Cardiovascular Risk Factors or Established Ischemic Heart Disease: A Joint FIGO and WHF Position Paper. [PDF]

Glob Heart
Benedetto C, Gulati M, Khadilkar SS, Maas AHEM, Frezet F, de Oliveira GMM, Genazzani AR, Divakar H, Poppas A, International Federation of Gynecology and Obstetrics (FIGO) and World Heart Federation (WHF).   +9 more
europepmc   +1 more source

Editorial: Menopause and mental health. [PDF]

Int J Gynaecol Obstet
Zahn K, Nathan M, Schiller C, Neal-Perry G.   +3 more
europepmc   +1 more source

Sex-specific reproductive and hormonal factors in relation to Alzheimer’s disease-related biomarkers: A Systematic Review

Näsholm MS, Karatas EG, Wang Y, Padilla P, Bereczki E, Aknes M, Bednorz A, Gong J, Ferreira D, Habich A, Ištvánfyová ZW, Kujawska-Danecka H, Lorenzon G, Mangialasche F, Marseglia A, Nalvarte I, Oltra J, Qiu C, Religa D, Xiong Y, Peltonen M, Mitra S, Kivipelto M, Maioli S, Sindi S.   +24 more
europepmc   +1 more source

Menopausal status and adjuvant hormonal therapy for breast cancer patients: A practical guideline [PDF]

Critical Reviews in Oncology/Hematology, 2012
Contains fulltext : 108650.pdf (Publisher’s version ) (Open Access)Breast cancer is the most common malignancy amongst women in the developed world.
J S E Laven, F Y F L de Vos
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Menopausal Hormone Therapy

Journal of Obstetrics and Gynaecology Canada, 2005
Although estrogen has been clinically available for more than 6 decades, women have been confused by different opinions regarding the risks and benefits of menopausal hormone therapy (HT), estrogen therapy (ET), and estrogen-progestin therapy (EPT).
Bhagu R, Bhavnani, Ronald C, Strickler
openaire   +3 more sources

EMAS position statement: Non-hormonal management of menopausal vasomotor symptoms

Maturitas, 2015
Aim: To review non-hormonal therapy options for menopausal vasomotor symptoms. The current EMAS position paper aims to provide to provide guidance for managing peri- and postmenopausal women who cannot or do not wish to take menopausal hormone therapy ...
Herman Depypere, Tommaso Simoncini
exaly   +4 more sources